Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency

NCT01704079 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
Hyperparathyroidism, Secondary
Vitamin D Deficiency

Interventions

DRUG: CTAP101 30 μg capsules
OTHER: Sugar pill to CTAP101 30 μg capsules

Sponsor

OPKO IP Holdings II, Inc.